HOB Biotech Group Corp.,Ltd (688656.SS)
CNY 102.72
(-1.37%)
CNY 102.72
(-1.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 138.52 Million CNY | -16.04% |
| 2022 | 164.98 Million CNY | 75.67% |
| 2021 | 93.91 Million CNY | 4.33% |
| 2020 | 90.02 Million CNY | -32.59% |
| 2019 | 133.54 Million CNY | 44.99% |
| 2018 | 92.1 Million CNY | 41.27% |
| 2017 | 65.19 Million CNY | -4.04% |
| 2016 | 67.93 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 196.8 Million CNY | 3.04% |
| 2024 Q1 | 159.92 Million CNY | 15.45% |
| 2024 Q2 | 190.99 Million CNY | 19.43% |
| 2023 Q3 | 152.34 Million CNY | 3.97% |
| 2023 FY | 138.52 Million CNY | -16.04% |
| 2023 Q1 | 140.39 Million CNY | -14.91% |
| 2023 Q4 | 138.52 Million CNY | -9.07% |
| 2023 Q2 | 146.52 Million CNY | 4.37% |
| 2022 Q4 | 164.98 Million CNY | 55.72% |
| 2022 Q3 | 105.94 Million CNY | 1.41% |
| 2022 Q2 | 104.47 Million CNY | 17.51% |
| 2022 Q1 | 88.9 Million CNY | -5.33% |
| 2022 FY | 164.98 Million CNY | 75.67% |
| 2021 Q1 | 66.94 Million CNY | -25.63% |
| 2021 Q2 | 70.5 Million CNY | 5.32% |
| 2021 FY | 93.91 Million CNY | 4.33% |
| 2021 Q4 | 93.91 Million CNY | 14.32% |
| 2021 Q3 | 82.15 Million CNY | 16.51% |
| 2020 FY | 90.02 Million CNY | -32.59% |
| 2020 Q4 | 90.02 Million CNY | 27.26% |
| 2020 Q3 | 70.73 Million CNY | 3.56% |
| 2020 Q2 | 68.3 Million CNY | -46.27% |
| 2020 Q1 | 127.12 Million CNY | -4.8% |
| 2019 Q4 | 133.54 Million CNY | 0.0% |
| 2019 FY | 133.54 Million CNY | 44.99% |
| 2018 FY | 92.1 Million CNY | 41.27% |
| 2017 FY | 65.19 Million CNY | -4.04% |
| 2016 FY | 67.93 Million CNY | 0.0% |